BioStartup News Newsletter
Press Releases, Financial News,
Media Coverage, Careers and Events |
* - May need subscription or registration to view |
|
|
|
|
FOUNDATION PARTNER
|
|
|
|
|
|
PRESS RELEASES
|
|
|
- ACELYRIN:. Adds Two Veteran C-suite Leaders More
- Arcutis: Positive Topline Results From INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis in Adults and Children Aged Six Years and Older More
- BRAINBox Solutions: Enrolls 1000th Patient in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test More
- Brain Scientific: Release of Improved NeuroCap(TM) and New US Distribution Deal With D&D Medical More
- BrainStorm Cell Therapeutics: Receives Refusal to File Letter From FDA for Its New Biologics License Application for NurOwn for the Treatment of ALS More
- Celularity: Imugene’s onCARlytics Combination With Placental-Derived Off-the-Shelf Allogeneic CYCART-19 T Cells Preclinical Data Presented at SITC Annual Meeting More
- Celularity: Presents Preclinical Data on CYNK-101, Its Allogeneic Genetically-Modified Natural Killer Cell Therapy Candidate, at the Society for Immunotherapy of Cancer's 37th Annual Meeting More
- Forte Biosciences: Dr. Scott Brun, M.D. Appointed to Board of Directors More
- Henley Ion: Merger With HGMT More
- Kriya: Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio More
- Lanier Biotherapeutics: Issuance of U.S. Patent for IL-25 Binding Molecules More
- Ontogen Medtech: Accelerates Growth With Opening of New Office in Western Chicago Suburbs More
- Portage Biotech: Clinical Trial Collaboration Agreement With Merck More
- Treadwell Therapeutics: Presentation at the 2022 SITC Annual Meeting Featuring a Clinical Trial Update on CFI-402411, a First-in-Class HPK1 Inhibitor More
|
CRO vs. CVO: What’s Best for Your Rodent Studies?
To outsource or keep in-house, this is a question many startups
need to consider.
Learn More |
|
|
|
|
|
|
|
FINANCIAL NEWS
|
|
|
|
- Biotech CEO Mark McKenna Explains What Drug Dealmaking Trends to Watch More*
- MBX Biosciences Closes on $115M in Drug-Development Funding More More
- Medtech Startup 410 Medical Lands New Cash Transfusion: $6.3 Million More
- Renibus Therapeutics: Raises $33 Million Bridge Financing to Advance Its Portfolio of Cardiorenal Product Candidates More
- Revenue-Based Financing: A New Playbook for Startup Fundraising More*
- Three Months After Leadership Change, vTv Therapeutics Reports Cash of $15.3 Million and Net Loss of $4.3 Million in Q3 More*
HOT INVESTOR MANDATES from NOVEMBER 10
- Hot Investor Mandate: VC Invests Up to $15M Exclusively in Life Sciences Companies, Most Interested in Novel Therapeutics With China Market Potential More
- Hot Investor Mandate: Venture Fund Focuses on Seed-Stage Investments in the Intersection of Science and Technology, Also Interested in Platform Technologies More
- Hot Investor Mandate: Venture Arm of Large Conglomerate Seeks to Invest in Biotech Therapeutics and Consumer-Facing Healthcare Technologies Across the Globe More
- Hot Investor Mandate: VC Backed By Investment Ecosystem of Accredited Investors Seeks Early-Stage Investments in Digital Health & Healthtech, Most Interested in USA-Based Companies More
|
| |
| SECTION SPONSOR: |
 |
|
|
|
|
|
|
MEDIA/MISC COVERAGE
|
|
|
|
- CincyTech-Backed Eikonoklastes Therapeutics Clears FDA Hurdle for First-in-Class ALS Treatment More
- Corporate Innovation Hubs and Healthcare Startups: The Perfect Match More
- Matt Adams Discusses the First Surgical Camera for Arthroscopy and General Endoscopy More
- Milwaukee Startup Rose Biosciences Says It Has Discovered a New Treatment for Obesity More
- Most Recent Tweets From BioStartup News More
|
| |
| SECTION SPONSOR: |
 |
|
|
|
|
|
COMPANIES
|
|
|
|
- US Life Science Startup Company Directory More
|
| |
| SECTION SPONSOR: |
 |
|
|
|
|
|
|
EVENT CENTER
|
|
|
|
- 22nd Annual Regional Biotechnology Conference: Innovating Innovation: Leveraging Lessons From COVID-19 Nov 17
- RESI: Pitching at the Biggest Partnering Event of the Year (Session 2) Nov 22
- BIOMEDevice Silicon Valley Nov 29-30
- LSPA: Legal Answers Workshop (LAW) Powered by Ballard Spahr LLP Dec 1
- NEHEN: Healthcare Financing IPO, Venture, Private Equity, and M&A Outlook 2023 Dec 5
- LSPA: Tell Me About Your DE&I Series - a Leadership Panel Dec 7
- Biocom California Bay Area Facilities Reception Dec 8
- QB3 Webinar: Ben Cravatt, Scripps Research Dec 12
- Trade & Channel Strategies 2022 Dec 12-14
- **SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR**
|
| |
| SECTION SPONSOR: |
 |
|
|
DON'T MISS THE NEWS AND DEVELOPMENTS FROM THE "BIG 4" BIOTECH HUBS IN THE WORLD!
SUBSCRIBE NOW TO BIG4BIO'S DAILY NEWSLETTERS
|
|
|
|
|
|
CAREER CENTER
|
|
|
|
- Scientist I-II, Resilience.Com - Alachua, FL More
- Scientist, Clinical Development, Umoja Biopharma - Seattle, WA / Boulder, CO More
- Head of Toxicology, Tenaya Therapeutics - South San Francisco, CA More
- VP, Clinical Operations, Tango Therapeutics - Boston, MA More
- Head of Clinical Operations, Scipher Medicine - Waltham, MA More
- Head of Translational Medicine, Terremoto Biosciences - South San Francisco, CA More
|
| |
| SECTION SPONSOR: |
 |
|
|
|
|
|
|
SPONSORS
|
|
|
|
|
|
|
|
